| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 |
| filingDate |
2013-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8251ef8f8bbbe74c237f64ef17d2708b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c4ee9fd08f6380aef2bf899c0d629b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bde97054fdcd175f5530618a0dc3a45f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff71aac29a9d5176c02167f93061b625 |
| publicationDate |
2014-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-104136028-A |
| titleOfInvention |
Highly effective soluble epoxide hydrolase non-urea inhibitor |
| abstract |
The present invention relates to compounds having vasodilatory and anti-inflammatory effects by inhibiting the activity of soluble epoxide hydrolase (sEH). The invention also relates to methods of identifying such compounds, and the use of such compounds for the treatment of diseases associated with vasodilation dysfunction, inflammation and/or endothelial cells. In a specific, non-limiting example, compounds of the invention are useful in the treatment of hypertension. |
| priorityDate |
2012-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |